Market Overview

Benzinga's Top Upgrades, Downgrades For September 5, 2018

Share:

Top Upgrades

  • Morgan Stanley upgraded BP plc (ADR) (NYSE: BP) from Equal-Weight to Overweight. BP shares fell 0.37 percent to close at $42.72 on Tuesday.
  • Barclays upgraded PerkinElmer, Inc. (NYSE: PKI) from Underweight to Equal-Weight. PerkinElmer shares rose 0.03 percent to close at $92.46 on Tuesday.
  • Morgan Stanley upgraded Anthem Inc (NYSE: ANTM) from Equal-Weight to Overweight. Anthem shares fell 0.39 percent to close at $263.70 on Tuesday.
  • Bernstein upgraded Vodafone Group Plc (ADR) (NASDAQ: VOD) from Market Perform to Outperform. Vodafone shares fell 0.05 percent to $21.24 in pre-market trading.

 

Top Downgrades

  • Barclays downgraded Hologic, Inc. (NASDAQ: HOLX) from Overweight to Equal-Weight. Hologic shares fell 0.10 percent to close at $39.72 on Tuesday.
  • Cowen & Co. downgraded K2M Group Holdings Inc (NASDAQ: KTWO) from Outperform to Market Perform. K2M Group shares fell 0.11 percent to close at $27.31 on Tuesday.
  • BMO Capital downgraded CSX Corporation (NASDAQ: CSX) from Outperform to Market Perform. CSX shares fell 1.48 percent to $73.73 in pre-market trading.
  • Macquarie downgraded Vail Resorts, Inc. (NYSE: MTN) from Outperform to Neutral. Vail Resorts shares rose 1.13 percent to close at $301.42 on Tuesday.
  • Goldman Sachs downgraded Robert Half International Inc. (NYSE: RHI) from Neutral to Sell. Robert Half shares fell 4.29 percent to $75.40 in pre-market trading.
  • Barclays downgraded Myriad Genetics, Inc. (NASDAQ: MYGN) from Equal-Weight to Underweight. Myriad Genetics shares rose 1.10 percent to close at $50.34 on Tuesday.
  • BMO Capital downgraded Canadian National Railway (USA) (NYSE: CNI) from Outperform to Market Perform. Canadian National Railway shares fell 1.68 percent to close at $87.42 on Tuesday.
  • Argus downgraded Tyson Foods, Inc. (NYSE: TSN) from Buy to Hold. Tyson Foods shares fell 0.59 percent to $62.38 in pre-market trading.

 

Top Initiations

  • Raymond James initiated coverage on Xylem Inc (NYSE: XYL) with an Outperform rating. The price target for Xylem is set to $90. Xylem shares closed at $75.66 on Tuesday.
  • Analysts at Barclays initiated coverage on Bio-Rad Laboratories, Inc. (NYSE: BIO) with an Equal-Weight rating. The price target for Bio-Rad is set to $345. Bio-Rad Laboratories shares closed at $326.15 on Tuesday.
  • Mitsubishi UFJ initiated coverage on Usa Compression Partners LP (NYSE: USAC) with an Overweight rating. The price target for Usa Compression Partners is set to $22. Usa Compression Partners shares closed at $16.66 on Tuesday.
  • Analysts at Imperial Capital initiated coverage on Mesa Air Group Inc (NASDAQ: MESA) with an Outperform rating. The price target for Mesa Air is set to $18. Mesa Air shares closed at $15.82 on Tuesday.
  • Barclays initiated coverage on Amalgamated Bank (NASDAQ: AMAL) with an Overweight rating. The price target for Amalgamated Bank is set to $20. Amalgamated Bank shares closed at $17.75 on Tuesday.
  • Stephens & Co. initiated Carvana Co (NYSE: CVNA) with an Equal-Weight rating. Carvana shares closed at $67.34 on Tuesday.
  • Wedbush initiated coverage on Liquidia Technologies (NASDAQ: LQDA) with an Outperform rating. The price target for Liquidia Technologies is set to $26. Liquidia Technologies shares closed at $17.39 on Tuesday.
  • Deutsche Bank initiated coverage on Caesars Entertainment Corporation (NASDAQ: CZR) with a Buy rating. The price target for Caesars Entertainment is set to $14. Caesars Entertainment shares closed at $9.90 on Tuesday.
  • Analysts at Roth Capital initiated coverage on Cyclacel Pharmaceuticals Inc (NASDAQ: CYCC) with a Buy rating. The price target for Cyclacel Pharmaceuticals is set to $8. Cyclacel Pharmaceuticals closed at $1.57 on Tuesday.
  • Analysts at Sandler O'Neill initiated coverage on Pacific City Financial Corp (NASDAQ: PCB) with a Buy rating. The price target for Pacific City Financial is set to $23. Pacific City Financial closed at $20.70 on Tuesday.

Posted-In: Initiations top upgradesUpgrades Downgrades Initiation Pre-Market Outlook Analyst Ratings

 

Related Articles (ANTM + AMAL)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
ACBIKeefe Bruyette & WoodsUpgrades21.0
COTYBMO CapitalUpgrades12.0
ECCOppenheimerDowngrades0.0
VYGRRaymond JamesUpgrades0.0
ATNXJP MorganUpgrades15.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Benzinga Pro's 6 Stocks To Watch Today

The Daily Biotech Pulse: Biohaven In-Licenses Drug, Retrophin's Debt Offering, ProQR And Bluebird Report Positive Trial Results